FDA approves the first clinical trials for pig kidney transplants in humans, testing genetically modified pig organs.

United Therapeutics is pioneering a new frontier in organ transplants using pig kidneys. STORY HIGHLIGHTS FDA clears United Therapeutics for human trials of pig-to-human kidney transplants.

United Therapeutics said the FDA has cleared it to begin the first clinical trial testing whether organs from gene-edited ...

Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), recently executed a series of stock ...

The second person ever has received a transplant with a genetically modified pig kidney.

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

Mass General Brigham has announced the successful completion of another gene-edited pig kidney transplant, the first of a ...

It was the fourth pig kidney transplant in the United States, and the first of three that will be done at Mass General as ...

The U.S. Food and Drug Administration has approved the first-ever clinical trials testing pig kidney transplants in people ...

United Therapeutics (UTHR) announced full enrollment of the TETON 1 study evaluating the use of Tyvaso or treprostinil, inhalation solution or ...

UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...

On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received a pig kidney transplant.